News
Smart Portfolio
TV
Notifications
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
TipRanksTV
New
STOCKS
BABA
AAPL
NIO
AMZN
AMC
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
New
Penny Stocks
U.S. Markets
Market Movers
Top Experts
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Dividend Yield Calculator
New
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
WallStreetBets Stocks
NFT Stocks
EV Stocks
Crypto Stocks
Dividend Stocks
Smart Portfolio
Overview
My Holdings
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Latest
Ideas & Insights
Popular
Dividend Stocks News
Penny Stocks News
FAANG Stocks News
TipRanks Labs
Crypto Stocks
About Us
About TipRanks
For Business
Careers
Become an Affiliate
Education Center
Reviews
Contact Us
Plans & Pricing
All News
Teva Pharmaceutical
Stock Latest News
Teva Hits FDA Hurdle, Slips 4.5% Pre-Market
Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) U.S. affiliate and MedinCell disclosed that the U.S. Food and Drug Administration (FDA)...
Apr 20, 2022
Teva Gains 6.4% on Another Opioid Case Settlement
Teva Pharmaceutical Industries’ (NYSE: TEVA) affiliate Teva Pharmaceuticals announced to have settled opioid-related claims with the state of...
Mar 31, 2022
Teva Settles Opioid Case with Rhode Island, Aims for National Settlement
Teva Pharmaceuticals (NYSE: TEVA) said that it has settled the opioid-related claims with the Attorney General of Rhode...
Mar 22, 2022
Teva to Pay $225M to Settle Texas’ Opioid-Related Claims
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has reached an agreement with the state of Texas to settle its...
Feb 08, 2022
Teva to Pay $420M to Settle Shareholders’ Generic Drug Pricing Lawsuit — Report
According to a report published by Reuters, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has agreed to settle a...
Jan 19, 2022
Teva Found Guilty of Fueling New York Opioid Crisis
New York jurors have held Teva Pharmaceuticals, a U.S. affiliate of Israel-based drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) liable for fueling...
Dec 31, 2021
Teva Long-Term Prospects Bright, Despite Headwinds
Teva Pharmaceuticals (TEVA) is a generic drug manufacturer. The firm provides patent treatments for migraines and multiple sclerosis...
Dec 29, 2021
Teva Partners with Tikun Olam-Cannbit to Sell Medical Cannabis Products – Report
According to a report published by Reuters, Teva Pharmaceutical Industries Ltd. (TEVA) has entered the medical cannabis market...
Dec 27, 2021
Teva Launches First Generic of Naloxone Hydrochloride Nasal Spray in the U.S.
Multinational pharmaceutical company Teva Pharmaceutical Industries Ltd. (TEVA) has launched the first generic version of naloxone hydrochloride nasal...
Dec 23, 2021
Wednesday’s Pre-Market: Here’s What You Need to Know Before the Market Opens
U.S. stock futures were down Wednesday morning and signaled a muted start to the trading day. The slide...
Jun 30, 2021
Teva, Bioeq Partner to Sell Lucentis Biosimilar
Teva Pharmaceutical (TEVA) has partnered with Bioeq for the commercialization of a biosimilar candidate to Lucentis. Swiss company...
Jun 30, 2021
Teva’s Seffalair And BroPair Spiromax Receive Approval In EU
Teva Pharmaceuticals Europe has received marketing authorization for Seffalair and BroPair Spiromax in the European Union to treat...
Apr 08, 2021
Teva Gets a Head Start Over Rivals With Launch of HIV Generics; Analyst Says ‘Buy’
Teva Pharmaceutical (TEVA) is not a company immune to controversy, but one long standing overhang might have just...
Oct 07, 2020
Teva Launches Two Digital Inhalers For Asthma Patients
Teva Pharmaceutical Industries launched two new digital inhalers AirDuo Digihaler and ArmonAir Digihaler in the US for patients...
Sep 22, 2020
Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan Nasal Spray
The U.S. District Court for the District of New Jersey has ruled in favor of Teva Pharmaceutical Industries...
Jun 07, 2020
You need to enable JavaScript to run this app.